Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 55%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · prior close shown (market closed)
Prelude Therapeutics Inc shows accelerating business momentum based on AlphaOS pipeline evidence.
3 signals not yet derived from pipeline evidence
Pipeline evidence · 0d ago
PRLD's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on PRLD.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for Prelude Therapeutics Inc (PRLD) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
PRLD's AI investment thesis
Upgrade to Premium for PRLD's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$4.31
Market cap
$343.95M
Profitable
No
Revenue $12.14M
Net income
$-99.50M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for Prelude Therapeutics Inc — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Prelude Therapeutics Inc through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.